Institute

medicine

Contemporary Pop Artist Todd Gray’s ‘Love Wins’ Debuts At The Lawrence J. Ellison Institute For Transformative Medicine Of USC In L.A.

LOS ANGELES, Dec. 1, 2020 /PRNewswire/ — A dramatic wall sculpture by leading contemporary pop artist Todd Gray of Los Angeles is now on exhibit at the innovative new home of The Lawrence J. Ellison Institute for Transformative Medicine of USC in West Los Angeles.

“Love Wins” by Todd Gray (65”H X 135”W X 15” D)

Gray’s Love Wins sculpture at the southeast side of the fifth floor near the Zen Garden was created with simple wooden geometric cubes, painted with brilliant acrylic colors and clean lines that reflect his unique visual language. It is the only three-dimensional wall sculpture at the Ellison Institute, and its bold design incorporates uplifting and emotional words contributed by the Institute’s clinic staff.

“The power of art to heal was evident to me when I painted Flabbergast, the outside mural near the World Trade Center,” said Gray.  “The vibe in the neighborhood was one of despair, but as thousands of people passed by daily and watched us work we could feel spirits lifting. By the time we were finished with Flabbergast, people were having their photos taken in front of it and jumping for joy, which was an enormous honor. My Ellison Institute work has been a true labor of love and is instilled with the same joy of life that I hope will definitely be contagious.”

The Ellison Institute is guided by Founding Director and CEO David B. Agus, MD, and tackles difficult questions in healthcare and medical research to push the boundaries of traditional medicine. Designed with collaboration in mind, the Institute’s converging research ecosystem is underscored by its multidisciplinary think-tank, which brings together physicians, scientists and thought leaders of disparate backgrounds from around the world to transform how cancer prevention, detection and treatment are approached.

Housed within a healing environment, the Ellison Institute’s collection of world class art showcases works from top artists, curated to inspire hope among patients, their families and visitors. The Ellison Institute is located at 12414 Exposition Boulevard, near West L.A.’s Expo/Bundy Station.

Todd’s work exudes vibrant color, energy, enthusiasm and a lust for life.  His sculpture will provide a beautiful and uplifting spirit to all who pass through the Institute’s doors in the years to come,” said Ellis Goodman, owner of CODA Gallery in Palm Desert, which was named the Best Gallery inCaliforniain 2017 and 2020 by the American Art Awards.

Pop art fans frequently visit the Todd Gray Studio website, online shop or text him at 1818-446-1105. Connect with Todd on Instagram @toddgray_studios or Facebook. To watch Todd creating “Love Wins” see video here.

For more information about Todd Gray, interviews or video footage contact: [email protected]  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/contemporary-pop-artist-todd-grays-love-wins-debuts-at-the-lawrence-j-ellison-institute-for-transformative-medicine-of-usc-in-la-301181712.html

SOURCE Todd Gray Studios

Source Article

Read More
medicine

Cebu Institute of Medicine named no. 1 medicine school nationwide


ALTHOUGH no Cebu-based takers made it to the top 10 of the November 2020 Physician Licensure Examinations (PLE), the Professional Regulatory Commission (PRC) named a Cebu-based medicine school as the number one performing school this year.

The Cebu Institute of Medicine (CIM) took the top spot after all of its 138 first-time takers passed the examinations, giving the school a 100 percent passing rate.

The CIM was followed by the University of the Philippines (UP) Manila with a 98.63 percent passing rate and the Ateneo School of Medicine and Public Health with 98.60 percent.

The PRC released the results of the November 2020 PLE on Thursday, Nov. 26, 2020, or seven working days after the last day of the examination.

The PRC said a total of 3,538 out of the 4,704 takers passed this year’s PLE administered by the Board of Medicine in the Cities of Manila, Baguio, Cagayan de Oro, Cebu, Davao, Iloilo, Legazpi, Lucena, Tacloban, Tuguegarao and Zamboanga.

A UP-Manila graduate, Jomel Lapides, emerged as the top 1 with a rate of 88.67 percent, followed by Patrick Joseph Mabugat from University of Saint La Salle and Adrian Teves from University of Sto. Tomas (UST) who both garnered 88.58 percent. Henrick Fong of UST and Raphael Rodolfo of UP Manila ranked third with a rate of 88.33 percent.

Among those who passed is Janine Patricia “Tricia” Robredo, a daughter of Vice President Maria Leonor “Leni” Robredo.

In a Twitter post Thursday morning, Robredo said: “Our children’s achievements are always sweeter than our own. Congratulations, Trish. Thank you for making us proud many times over.”

Lapides, a graduate of UP Manila, topped the examination with a rating of 88.67 percent.

Seven other UP Manila graduates were among the 20 examinees who landed in the top 10 slots.

Only one examinee from outside Luzon made it to the top 10.

The certificate of registration and the registration for the issuance of professional ID will be done online beginning Jan. 11 to 29 next year. (WBS / Marites Villamor-Ilano / SunStar Philippines)

Source Article

Read More
medicine

Cebu Institute of Medicine ranks 1st among top performing school in physician exam


ALTHOUGH no Cebu-based graduates made it to the top 10 of the November 2020 Physician Licensure Examinations (PLE), the Professional Regulatory Commission (PRC) named a Cebu-based medicine school as the top 1 among the top performing schools this year.

The Cebu Institute of Medicine (CIM) ranked first among the top ten performing schools in the November 2020 PLE after all of its 138 first time-takers have passed the examinations, giving the school a 100 percent passing rate.

The CIM was followed by the University of the Philippines (UP)-Manila with 98.63 percent passing rate and Ateneo School of Medicine and Public Health with 98.60 percent.

The PRC released the results of the November 2020 PLE on Thursday, November 26, 2020 or seven working days after the last day of the examination.

The PRC said a total of 3,538 out of the 4,704 takers passed this year’s PLE administered by the Board of Medicine in the Cities of Manila, Baguio, Cagayan de Oro, Cebu, Davao, Iloilo, Legazpi, Lucena, Tacloban, Tuguegarao and Zamboanga.

A UP-Manila graduate, Jomel Lapides, emerged as the top 1 with a rate of 88.67 percent, followed by Patrick Joseph Mabugat from University of Saint La Salle and Adrian Teves from University of Sto. Tomas (UST) who both garnered 88.58 percent while both Henrick Fong of UST and Raphael Rodolfo of UP-Manila ranked third with a rate of 88.33 percent. (WBS)

Source Article

Read More
dentist

Local Dentist forms California Institute for Dental Implants

A local dentist develops new dental implant surgery and placement to give more people a chance at a healthy smile.

After years of using multiple systems to perform dental implant surgery and implant placement, Dr. Sean Mohtashami of All Bright Dental created his own and called it the 4M Dental Implant Solution. The 4M Dental Implant Solution gives patients with unhealthy or missing teeth an opportunity to get dental implants, even if they have been told they do not have enough bone.

“I developed my system after many years of using several other world-renowned dental implant systems,” says Dr. Sean. “I have always felt there must be a better way, and so I addressed every step of the procedure. My team and I developed a solution that is easier, faster, and more comfortable for the patient. We still use the All-On-4® procedure for full-mouth restorations, but we’ve also designed and developed some incredibly durable and natural-looking implants for single tooth and full-arch replacements.”

Dr. Sean, as his patients like to call him, wanted to expand, and he began traveling to Southern California to place implants for other dentists in their offices. He opened his first 4M Dental Implant Center in Newport Beach, California in 2017. Since then, he has opened two more offices, in Anaheim Hills and Long Beach, California.

To complete the circle of helping as many people as possible, Dr. Sean opened the 4M Institute, to teach dentists the advanced art and science of dental implants. “I am humbled by the excitement other dentists have shown to learn the 4M procedures and techniques,” says Dr. Sean. “It has been my hope to help as many people as possible with dental implants. I never dreamed that I would be able to help so many. I genuinely believe that 4M is the simplest and most comfortable solution to missing teeth, especially for those needing a full arch of teeth.”

Dentistry is ever changing, with stronger and more natural looking materials. Complex procedures are becoming mainstream, and faster and less painful techniques are giving patients better results quicker and more comfortably than ever before. Teaching dentists advanced skills and improving their practices enables Dr. Sean and his team at All Bright Dental and 4M Dental Implant Center to positively impact the lives of patients around the world.

See before and after photos and videos of actual patients, and learn more about our full arch All-on-4®, 4M dental implant system at www.AllBrightSmile.com.

Members of the editorial and news staff of the Las Vegas Review-Journal were not involved in the creation of this content.

Source Article

Read More
medicine

Rocket Pharmaceuticals Receives Funding from the California Institute for Regenerative Medicine for Phase 1 Clinical Trial of RP-L401 for Infantile Malignant Osteopetrosis

NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces that the California Institute for Regenerative Medicine (CIRM) has awarded Rocket a $3.7 million CLIN2 grant award to support the clinical development of its lentiviral vector (LVV)-based gene therapy, RP-L401, for the treatment of Infantile Malignant Osteopetrosis (IMO), a rare, severe monogenic bone resorption disorder characterized by skeletal deformities, neurologic abnormalities and bone marrow failure. The CIRM was founded in 2004 following the passing of Proposition 71 or the California Stem Cell Research and Cures Initiative, which allowed $3 billion in state funding for stem cell research conducted in California. This will be Rocket’s second CIRM grant after receiving one in 2019 for the development of the company’s gene therapy for Leukocyte Adhesion Deficiency-I (LAD-I).

“We’re grateful the CIRM has recognized the promise of RP-L401 for IMO, a devastating pediatric rare disease for which the primary treatment option is allogeneic bone marrow transplant,” said Jonathan Schwartz, M.D. Chief Medical Officer and Senior Vice President of Rocket. “RP-L401 could be a potentially curative treatment for this devastating disorder that affects children at a young age, and we are thankful to have this meaningful support from the CIRM to move our program forward for these families.”

Rocket’s Investigational New Drug Application (IND) for RP-L401 was accepted by the U.S. Food and Drug Administration (FDA) in June of 2020, and the gene therapy received Fast Track designation from the FDA in August 2020. Proceeds from the grant will help fund clinical trial costs, as well as provide manufactured drug product for Phase 1 patients enrolled at the U.S. clinical trial site, University of California, Los Angeles, led by principal investigator Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics, Pediatrics (Hematology/Oncology), Molecular and Medical Pharmacology, and member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California, Los Angeles. The non-randomized, open-label Phase 1 clinical trial will enroll two pediatric patients, one month of age or older. The trial is designed to assess safety and tolerability of RP-L401, as well as preliminary efficacy, including potential improvements in bone abnormalities/density, hematologic status and endocrine abnormalities. Further information about the clinical program is available here.

About Infantile Malignant Osteopetrosis

Infantile Malignant Osteopetrosis (IMO) is a rare, severe autosomal recessive disorder caused by mutations in the TCIRG1 gene, which is critical for the process of bone resorption. Mutations in TCIRG1 interfere with the function of osteoclasts, cells which are essential for normal bone remodeling and growth, leading to skeletal malformations, including fractures and cranial deformities which cause neurologic abnormalities including vision and hearing loss. Patients often have endocrine abnormalities and progressive, frequently fatal bone marrow failure. As a result, death is common within the first decade of life. IMO has an estimated incidence of 1 in 200,000. The only treatment option currently available for IMO is an

Read More
medicine

Harrington Discovery Institute At University Hospitals And Case Western Reserve School Of Medicine Open Call For 2021 Harrington-MSTP Scholar Award

CLEVELAND, Nov. 10, 2020 /PRNewswire/ — Harrington Discovery Institute at University Hospitals and Case Western Reserve University School of Medicine have issued a call for proposals for the 2021 Harrington-MSTP (Medical Scientist Training Program) Scholar Award to help the next generation of physician-scientists advance their discoveries into breakthrough medicines. This program is a two-year scholarship for MSTP students at the School of Medicine whose work has been identified as innovative, creative and having potential to progress towards clinical application.

Since its founding in 2012, Harrington Discovery Institute–part of The Harrington Project for Discovery & Development–has supported 137 drugs-in-the-making in the US, Canada and the United Kingdom. Core to its mission, Harrington Discovery Institute recognizes and supports inventive physician-scientists through dedicated programs, including the global Harrington Prize (partnered with The American Society for Clinical Investigation), North American Scholar-Innovator Award, and the Cleveland, Ohio-based Harrington Investigator programs. With this program, now in its second year, the Institute has expanded its model to include the next generation of physician-scientists early in their career.

Through this award, Harrington Discovery Institute and the School of Medicine combine resources and capabilities to advance into new medicines the most promising research of Case MSTP students. Awardees will receive grant funding and dedicated therapeutic development support from Harrington Discovery Institute’s Therapeutics Development team, who are pharma-experienced industry leaders with a track record of bringing drugs to market.

“We are committed to helping physician-scientists improve the standard of care and address unmet needs in healthcare through their research. This program helps students take promising scientific discoveries and chart a path forward that maximizes potential for clinical success. Now more than ever, it is essential that we help close the gap between breakthroughs in the lab and much-needed treatments for patients. We are pleased to work closely with Case Western Reserve University to provide this opportunity,” said Jonathan S. Stamler, MD, President, Harrington Discovery Institute, Robert S. and Sylvia K. Reitman Family Foundation Distinguished Chair of Cardiovascular Innovation and Professor of Medicine at University Hospitals and Case Western Reserve University.

“This program provides tremendous value for the students selected, which they will carry with them throughout their careers. In working with former pharma executives, awardees are able to build new skills and gain a broader understanding of their research in relation to industry. The Case MSTP program has always focused on cultivating an innovation mindset with our students and providing them with the tools necessary for a successful career,” said Derek Abbott, MD, PhD, Program Director, Medical Scientist Training Program, Case Western Reserve School of Medicine.

Interested applicants from Case Western Reserve University’s MSTP program are asked to submit a Letter of Intent by December 7, 2020. Up to two award recipients will be selected and announced in spring 2021. For more information, visit: HarringtonDiscovery.org/MSTP.

Harrington Discovery Institute

The Harrington Discovery Institute at University Hospitals in Cleveland, OH — part of The Harrington Project for Discovery & Development — aims to advance

Read More
health

Billions of Dollars for Stem Cell Research Institute On California’s November Ballot

SACRAMENTO, Calif.—In an election year dominated by a chaotic presidential race and splashy statewide ballot initiative campaigns, Californians are being asked to weigh in on the value of stem cell research—again.

Proposition 14 would authorize the state to borrow $5.5 billion to keep financing the California Institute for Regenerative Medicine (CIRM), currently the second-largest funder of stem cell research in the world. Factoring in interest payments, the measure could cost the state roughly $7.8 billion over about 30 years, according to an estimate from the nonpartisan state Legislative Analyst’s Office.

In 2004, voters approved Proposition 71, a $3 billion bond, to be repaid with interest over 30 years. The measure got the state agency up and running and was designed to seed research.

During that first campaign, voters were told research funded by the measure could lead to cures for cancer, Alzheimer’s and other devastating diseases, and that the state could reap millions in royalties from new treatments.

Yet most of those ambitions remain unfulfilled.

“I think the initial promises were a little optimistic,” said Kevin McCormack, CIRM’s senior director of public communications, about how quickly research would yield cures. “You can’t rush this kind of work.”

So advocates are back after 16 years for more research money, and to increase the size of the state agency.

Stem cells hold great potential for medicine because of their ability to develop into different types of cells in the body, and to repair and renew tissue.

When the first bond measure was adopted in 2004, the George W. Bush administration refused to fund stem cell research at the national level because of opposition to the use of one kind of stem cell: human embryonic stem cells. They derive from fertilized eggs, which has made them controversial among politicians who oppose abortion.

Federal funding resumed in 2009, and thus far this year the National Institutes of Health has spent about $321 million on human embryonic stem cell research.

But advocates for Proposition 14 say the ability to do that research is still tenuous. In September, Republican lawmakers sent a letter to President Donald Trump urging him to cut off those funds once again.

The funding from California’s original bond measure was used to create the new state institute and fund grants to conduct research at California hospitals and universities for diseases such as blood cancer and kidney failure. The money has paid for 90 clinical trials.

A 2019 report from the University of Southern California concluded the center has contributed about $10.7 billion to the California economy, which includes hiring, construction and attracting more research dollars to the state. CIRM funds more than 56,500 jobs, more than half of which are considered high-paying.

Despite the campaign promises, just two treatments developed with some help from CIRM have been approved by the Food and Drug Administration in the past 13 years, one for leukemia and one for scarring of the bone marrow.

But it’s a bit of a stretch for the institute to take

Read More
medicine

Contakt World Enters 3-Year Strategic Collaboration with Satcher Health Leadership Institute at Morehouse School of Medicine

Partnership to Improve Health Equity, Reduce Health Disparities, and Improve Community Health Amid COVID-19 Pandemic

OCEANSIDE, CA / ACCESSWIRE / October 22, 2020 / Contakt LLC, subsidiary of Contakt World Technologies Corp. (“Contakt World”), a technology company modernizing the contact tracing process, today announced a strategic partnership with the Satcher Health Leadership Institute (SHLI) at Morehouse School of Medicine to provide COVID-19 resources and the Contakt World Platform for digital contact tracing to support communities hardest hit by the pandemic. Over three years, Contakt will assist SHLI and local, state, and national health agency partners to identify, monitor and support marginalized populations who are at heightened risk of exposure and complications from coronavirus. The program is expected to reach all fifty United States and territories, as well as tribal nations disproportionately impacted by the COVID-19 pandemic.

SHLI is a leading academic institute within Morehouse School of Medicine that prioritizes research, training, and leadership development programs to eliminate inequities that prevent individuals from achieving optimal health. SHLI is leading several national projects to mitigate the impact of COVID-19 on vulnerable and underserved communities, including the the National Infrastructure for Mitigating the Impact of COVID-19 funded by the U.S. Department of Health and Human Services (HHS), and the Health Equity Tracker project with Google.org, CDC Foundation, and Gilead Sciences (NASDAQ: GILD). Both projects aim to understand the root cause of the disproportionate spread of COVID-19 and other co-morbidities in minority communities and provide accessible health solutions. As part of the 3-year initial term between Contakt World and SHLI – Contakt World intends to obtain United States entitlements to use the Google-Apple Exposure Notification System (“GAEN”), while adding functionality across an array of tools for consumers, health agencies, and businesses to improve health agency reach to marginalized populations who may not have access to the latest smartphones using GAEN.

“We are honored to partner with SHLI on this project to improve the overall health of all communities and provide the right tools and resources to communities fighting the COVID-19 pandemic,” said Justin Beck, Chief Executive Officer of Contakt World. “Any system designed for truly scaled digital contact tracing must be deliberately accessible and reach people where they are. We look forward to working with SHLI to ensure that no person is denied critical health information due to digital divides, language barriers or other limitations of trust or technology.”

Contakt World will enable any community working with SHLI with technologies to support their efforts to serve high risk areas. The Contakt World Platform will initially be available through the SHLI collaboration in Albany, GA., South Florida, New Orleans, LA., Moore County, TX., Alaska, Navajo Nation with plans to expand to all 50 states and territories within the next three years or earlier by request.

“COVID-19 has exposed and exacerbated health inequities that have existed long before the pandemic started earlier this year,” said Daniel E. Dawes, Director of the Satcher Health Leadership Institute at Morehouse School of Medicine and author of The Political

Read More
health

Omkar Marathe, MD, of The Oncology Institute of Hope and Innovation Selected for 40 Under 40 in Cancer Award

Award recognizes the contributions made by the nation’s most promising oncology professionals under the age of 40

The Oncology Institute of Hope and Innovation (TOI) is proud to announce that Omkar Marathe, MD, a TOI physician, has received the “40 Under 40 in Cancer” award.

The 40 Under 40 in Cancer award celebrates the contributions of emerging leaders in cancer care under the age of 40. The award’s sponsors include the Association for Value-Based Cancer Care.

Dr. Marathe treats patients with cancer and blood disorders in the greater Long Beach Area and has received a teaching award for his work with the St. Mary’s Internal Medicine residency program. He has conducted research and published papers in various disciplines of oncology including ocular melanoma and HER2+ breast cancer and was recently named Director for TOI’s highly esteemed clinical trials program. Dr. Marathe is fluent in English, Spanish, Marathi, and conversational Hindi.

Brad Hively, TOI’s CEO, commented: “All of us at The Oncology Institute are incredibly proud of our colleague Dr. Marathe for being selected for this award. He represents what’s best about our company: a dedicated and talented clinician providing innovative and compassionate cancer care to our patients.”

About The Oncology Institute of Hope and Innovation

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is one of the largest community oncology practices in the US as well as our nation’s leading value-based oncology services platform. TOI employs 75 physicians and mid-level practitioners in 42 clinic locations, with more than 500 total employees helping to offer leading-edge, evidence-based cancer care to a population of more than 1.5 million patients. TOI brings comprehensive, integrated cancer care into community settings, including clinical trials, palliative care programs, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced tertiary care settings. For more information visit www.theoncologyinstitute.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201021005253/en/

Contacts

Julie Korinke
Senior Manager, Marketing
562.735.3226 x.88806
[email protected]

Source Article

Read More
dentist

Vegas Dentist Opens Dental Implant Institute and More Locations

In 1997, Dr. Sean Mohtashami opened All Bright Dental in Las Vegas, Nevada. It thrived as a general dental practice and later as a cosmetic dental practice. However, Dr. Sean (as his patients call him), wanted to help his patients even more and dove head first into dental implant dentistry. Upon seeing his implant patients’ remarkable emotional and physical changes, Dr. Sean fell in love with the process.

After years of using multiple ‘systems’ to perform dental implant surgery and implant placement, he created his own system he calls the 4M Dental Implant System. The 4M procedure and technique is the result of Dr. Sean’s obsession to improve on everything he does. The 4M Dental Implant solution gives patients who have unhealthy or missing teeth and thinning bone an opportunity for a new smile.

“I developed my system after many years of using several other world-renowned dental implant systems,” says Dr. Sean. “I have always felt there must be a better way, and so I addressed every step of the procedure. My team and I developed a system that is easier, faster, and more comfortable for the patient. We also designed and developed some incredibly durable and natural-looking implants for single tooth and full arch replacements.”

Dr. Sean had many dental implant patients in the Las Vegas valley but wanted to help more. Looking to expand, he began traveling to Southern California and placing implants as an associate for other dentists. he opened his first 4M Dental Implant Center in Newport Beach, California in 2017, bringing the 4M Dental Implant solution to Southern California. Since then he has opened two more offices, in Anaheim Hills and Long Beach, California.

To complete the circle of helping as many people as possible, Dr. Sean opened a teaching institute, the 4M Institute, to teach dentists the advanced art and science of dental implants. “I am incredibly humbled by the excitement other dentists have to learn the 4M procedures and techniques,” says Dr. Sean. “It has been my hope to help as many people as possible with dental implants, but I never dreamed that I would be able to help so many. It is an honor for sure. I truly believe that 4M is the simplest and most comfortable solution to missing teeth, especially for those needing a full arch of teeth.”

Dentistry is ever changing, with stronger and more natural looking materials. Complex procedures are becoming mainstream, and faster and less painful techniques are giving patients better results quicker and more comfortably than ever before. Teaching dentists advanced skills and improving their practices enables Dr. Sean and his team at 4M Dental Implant Center to positively impact the lives of patients around the world.

Come to the Founder of the 4M Institute

where dentists go to learn the art and science of dental implants

“receive two sets of hybrids, not dentures. You will receive both your temporaries (same day),

and your second, permanent set for one price. This is a zirconia bridge or

Read More